02 nguyen t hong van ta
Transcript of 02 nguyen t hong van ta
![Page 1: 02 nguyen t hong van ta](https://reader031.fdocuments.us/reader031/viewer/2022020307/55a4f87d1a28ab9a6e8b462f/html5/thumbnails/1.jpg)
![Page 2: 02 nguyen t hong van ta](https://reader031.fdocuments.us/reader031/viewer/2022020307/55a4f87d1a28ab9a6e8b462f/html5/thumbnails/2.jpg)
12/03/14Covidien | | Confidential2 |
![Page 3: 02 nguyen t hong van ta](https://reader031.fdocuments.us/reader031/viewer/2022020307/55a4f87d1a28ab9a6e8b462f/html5/thumbnails/3.jpg)
12/03/14Covidien | | Confidential3 |
![Page 4: 02 nguyen t hong van ta](https://reader031.fdocuments.us/reader031/viewer/2022020307/55a4f87d1a28ab9a6e8b462f/html5/thumbnails/4.jpg)
• N. T. H. 34 year old. 2012. Housekeper. Bình Phước
• Time and date: 15g30’ - 15/09/2006
: Multipara, cephalic presentation / two previous
cesarean delivery
• The time of this Cesarean delivery: 9h20
• Anesthesia management: spinal anesthesia
![Page 5: 02 nguyen t hong van ta](https://reader031.fdocuments.us/reader031/viewer/2022020307/55a4f87d1a28ab9a6e8b462f/html5/thumbnails/5.jpg)
Spinal anesthesia
![Page 6: 02 nguyen t hong van ta](https://reader031.fdocuments.us/reader031/viewer/2022020307/55a4f87d1a28ab9a6e8b462f/html5/thumbnails/6.jpg)
10h Cesarean delivery
![Page 7: 02 nguyen t hong van ta](https://reader031.fdocuments.us/reader031/viewer/2022020307/55a4f87d1a28ab9a6e8b462f/html5/thumbnails/7.jpg)
• After close the myometrial, the pateint have cyanotic, tachypnea, and decreased breathsounds
• Signs of right ventricular failure: an split second heart sound, jugular venous distension
• ECG : right-axis shift, P pulmonale, ST-T segment abnormalities, T-wave inversion, supraventricular arrhythmias.
• Cardiac arret
• Make CPR and reanimation
![Page 8: 02 nguyen t hong van ta](https://reader031.fdocuments.us/reader031/viewer/2022020307/55a4f87d1a28ab9a6e8b462f/html5/thumbnails/8.jpg)
13h55’ Atony uterus: Hysterectomy after cesarean 4h Disorder of coagulation: platelet: 221000, TP: 16%, TCK: 70”, Fib 29mg%, RC (-)
![Page 9: 02 nguyen t hong van ta](https://reader031.fdocuments.us/reader031/viewer/2022020307/55a4f87d1a28ab9a6e8b462f/html5/thumbnails/9.jpg)
Treatment disorder of coagulation
![Page 10: 02 nguyen t hong van ta](https://reader031.fdocuments.us/reader031/viewer/2022020307/55a4f87d1a28ab9a6e8b462f/html5/thumbnails/10.jpg)
• ELISA D-Dimer : 530
1.Chest radiographs: an elevated hemidiaphragm, and a peripheral segmental infiltrate
2.Spiral CT: thromboembolie of right segmental pulmonary arteries
3.Echocardiographic: dilation of right ventricular
![Page 11: 02 nguyen t hong van ta](https://reader031.fdocuments.us/reader031/viewer/2022020307/55a4f87d1a28ab9a6e8b462f/html5/thumbnails/11.jpg)
![Page 12: 02 nguyen t hong van ta](https://reader031.fdocuments.us/reader031/viewer/2022020307/55a4f87d1a28ab9a6e8b462f/html5/thumbnails/12.jpg)
INCIDENT
− Pulmonary thromboembolism (PTE) occurs in approximately 0.01%--0.05% of all pregnancies.1,2
− The most common etiology is deep vein thrombosis (DVT).
− Deep vein thrombosis occurs in 0.02% to 0.36% of pregnancies.3
1.Weiner CP. Clin Obstet Gynecol 1985; 28:107-18.
2.Gherman RB, Goodwin TM, Leung B, et al. Obstet Gynecol 1999; 94:730-4
3.Rothbard MJ ,Gluck D, Stone ML .NY State Jmed 1976;76:582-4.
12/03/14Covidien | | Confidential12 |
![Page 13: 02 nguyen t hong van ta](https://reader031.fdocuments.us/reader031/viewer/2022020307/55a4f87d1a28ab9a6e8b462f/html5/thumbnails/13.jpg)
12/03/14Covidien | | Confidential13 |
![Page 14: 02 nguyen t hong van ta](https://reader031.fdocuments.us/reader031/viewer/2022020307/55a4f87d1a28ab9a6e8b462f/html5/thumbnails/14.jpg)
12/03/14Covidien | | Confidential14 |
![Page 15: 02 nguyen t hong van ta](https://reader031.fdocuments.us/reader031/viewer/2022020307/55a4f87d1a28ab9a6e8b462f/html5/thumbnails/15.jpg)
12/03/14Covidien | | Confidential15 |
![Page 16: 02 nguyen t hong van ta](https://reader031.fdocuments.us/reader031/viewer/2022020307/55a4f87d1a28ab9a6e8b462f/html5/thumbnails/16.jpg)
ETIOLOGY
− Pregnancy: twofold - fivefold increase in the relative risk of thromboembolism.4,5
− Result of at least three factors:
1.An increase in venous stasis
2.The hypercoagulable state of pregnancy
3.The vascular injury associated with vaginal or cesarean delivery
4.Stein PD, Hull RD, Kayali F, et al. Am J Med 2004; 117:121-5.
5.Heit J, Kobberveg C, Petterson T, et al. Ann Intern Med 2005; 143:697-706.
12/03/14Covidien | | Confidential16 |
![Page 17: 02 nguyen t hong van ta](https://reader031.fdocuments.us/reader031/viewer/2022020307/55a4f87d1a28ab9a6e8b462f/html5/thumbnails/17.jpg)
VENOUS STASIS
− Maternal blood volume and cardiac output increase approximately 50% during pregnancy.6
− The gravid uterus compresses the inferior vena cava as well as other anatomic structures .
− Vena caval compression results in venous stasis distal to the compression in the pelvis and lower extremities
6.Palmer SK, Zamudio S, Coffin C, et al.. Obstet Gynecol 1992; 80:1000-6.
12/03/14Covidien | | Confidential17 |
![Page 18: 02 nguyen t hong van ta](https://reader031.fdocuments.us/reader031/viewer/2022020307/55a4f87d1a28ab9a6e8b462f/html5/thumbnails/18.jpg)
CHANGES IN COAGULATION
• Pregnancy:enhanced platelet turnover, coagulation, and fibrinolysis.
• Increase clotting factors: fibrinogen, V, VII, VIII, IX, X, and XII.
• Parturition accelerates platelet activation, coagulation, and fibrinolysis.7,8
.7.Gerbasi FR, Bottoms S, Farag A, et al. Obstet Gynecol 1990; 75:385-9.
8.Gerbasi FR, Bottoms S, Farag A, et al.. Am J Obstet Gynecol 1990; 162:1158-63
12/03/14Covidien | | Confidential18 |
![Page 19: 02 nguyen t hong van ta](https://reader031.fdocuments.us/reader031/viewer/2022020307/55a4f87d1a28ab9a6e8b462f/html5/thumbnails/19.jpg)
VASCULAR DAMAGE
− Both vaginal delivery and separation of the placenta result in vascular trauma, leading to an acceleration of coagulation activity.
− Cesarean delivery increase the risk of thromboembolism.
− DVT and PTE are as much as eight times higher after cesarean delivery than after vaginal. 9,10
.
9.Ros HR, Lichtenstein P, Bellocco R, et al. Am J Obstet Gynecol 2002; 186:198-203.
10. Lindqvist P, Dahlback B, Marsal K. . Am Coll Obstet Gynecol 1999; 94:595-9.
12/03/14Covidien | | Confidential19 |
![Page 20: 02 nguyen t hong van ta](https://reader031.fdocuments.us/reader031/viewer/2022020307/55a4f87d1a28ab9a6e8b462f/html5/thumbnails/20.jpg)
OBSTETRIC CONDITIONS
− Higher risk of PTE in women preeclampsia and multiple gestation (increased relative risks of sevenfold to eightfold, and twofold to threefold, respectively). 11,12,13
− These obstetric conditions or their management are associated with risk factors for thromboembolic disease
11.Ros HR, Lichtenstein P, Bellocco R, et al. Am J Obstet Gynecol 2002; 186:198-203.
12.Lindqvist P, Dahlback B, Marsal K.. Am Coll Obstet Gynecol 1999; 94:595-9.
13.James AH, Tapson VF, Goldhaber SZ. . Am J Obstet Gynecol 2005; 193:216-9.
12/03/14Covidien | | Confidential20 |
![Page 21: 02 nguyen t hong van ta](https://reader031.fdocuments.us/reader031/viewer/2022020307/55a4f87d1a28ab9a6e8b462f/html5/thumbnails/21.jpg)
COINCIDENTAL DISEASE
− A history of previous thromboembolism increases the risk of PTE during pregnancy 13
− Heart disease (odds ratio [OR], 7.1), smoking (OR, 1.7), obesity (OR,4.4), antiphospholipid antibody syndrome (OR, 15.0), thrombophilias (OR, 25.0 to 50.0).14,15,16
13. Bremme K, Lind H, Blomback M. . Obstet Gynecol 1993; 78:78-83
14.Lindqvist P, Dahlback B, Marsal K. . Am Coll Obstet Gynecol 1999; 94:595-9.
15. Sipes SL, Weiner CP. Semin Perinatol 1990; 14:103-18.
16.Bonnar J. Clin Obstet Gynecol 1981; 8:455-73
12/03/14Covidien | | Confidential21 |
![Page 22: 02 nguyen t hong van ta](https://reader031.fdocuments.us/reader031/viewer/2022020307/55a4f87d1a28ab9a6e8b462f/html5/thumbnails/22.jpg)
PATHOPHYSIOLOGY
The manifestations and prognosis of PTE depend on
1.The size and number of emboli
2.Concurrent cardiopulmonary function,
3.The rate of clot fragmentation and lysis,
4.The presence or absence of a source for recurrent emboli
5.The location of the embolism17,18
17.Stein PD, Beemath A, Matta F, et al. :. Am J Med 2007; 120:871-9.
18..Spence TH.. In Civetta JM, Taylor RM, Kirby RR, Philadelphia, JB Lippincott, 1988:1091-2
12/03/14Covidien | | Confidential22 |
![Page 23: 02 nguyen t hong van ta](https://reader031.fdocuments.us/reader031/viewer/2022020307/55a4f87d1a28ab9a6e8b462f/html5/thumbnails/23.jpg)
TREATMENT
Approximately 10% of all patients with a pulmonary embolus die within the first hour. 19
Therapy focuses on providing:1. Dequate maternal and fetal oxygenation2. Support of maternal circulation, including
uteroplacental perfusion3. Immediate anticoagulation or venous
interruption to prevent recurrence of a pulmonary embolus.20
19.Dalen JE, Alpert JS. Cardiovasc Dis 1975; 17:259-70
20.Spence TH. In Civetta JM, Taylor RM, Kirby RR, editors. Critical Care. Philadelphia, JB Lippincott, 1988:1091-2.
.
12/03/14Covidien | | Confidential23 |
![Page 24: 02 nguyen t hong van ta](https://reader031.fdocuments.us/reader031/viewer/2022020307/55a4f87d1a28ab9a6e8b462f/html5/thumbnails/24.jpg)
TREATMENT
− DEEP VEIN THROMBOSIS
− LMWH for both prophylactic and therapeutic anticoagulation during pregnancy has become common place.21
− LMWH has greater antithrombotic activity (anti-factor Xa) than anticoagulant activity (anti-factor IIa), it does not affect the aPTT.
.
21.American College of Obstetricians and Gynecologists Committee on Practice.. ACOG Practice Bulletin No. 19. Washington, DC, August 2000.
12/03/14Covidien | | Confidential24 |
![Page 25: 02 nguyen t hong van ta](https://reader031.fdocuments.us/reader031/viewer/2022020307/55a4f87d1a28ab9a6e8b462f/html5/thumbnails/25.jpg)
TREATMENT
Enoxaparin (Lovenox), injected once or twice daily at a dose of 40mg(1mg=100U), for thromboprophylaxis during pregnancy.22
Peak anti-factor Xa activity occurs within 3 to 5 hours of administration, and 50% of the total antifactor Xa activity disappears within 6 hours.23
Both the efficacy and the maternal and fetal safety of LMWH have been established.
22.Eisenach JC. . American Society of Regional Anesthesia. ASRA News 1995;Nov:5-6.
23.American College of Obstetricians and Gynecologists Committee on Practice.. ACOG Practice Bulletin No. 19. Washington, DC, August 2000.
12/03/14Covidien | | Confidential25 |
![Page 26: 02 nguyen t hong van ta](https://reader031.fdocuments.us/reader031/viewer/2022020307/55a4f87d1a28ab9a6e8b462f/html5/thumbnails/26.jpg)
CONCLUSION
Appropriate treatment of DVT reduces the incidence of PTE to 0.7% to 4.5%, 24,25 and it reduces the mortality rate to 0.7%.25,26
Anesthesia providers are often involved in the resuscitation of patients with embolic disorders
Early recognition, diagnosis, and treatment are necessary to reduce associated morbidity and mortality.
24. Rothbard MJ, Gluck D, Stone ML. . N Y State J Med 1976; 76:582-4
25.Villasanta U.. Am J Obstet Gynecol 1965; 93:142-60.
26. Sipes SL, Weiner CP. Semin Perinatol 1990; 14:103-18.
.
12/03/14Covidien | | Confidential26 |
![Page 27: 02 nguyen t hong van ta](https://reader031.fdocuments.us/reader031/viewer/2022020307/55a4f87d1a28ab9a6e8b462f/html5/thumbnails/27.jpg)
12/03/14Covidien | | Confidential27 |
VIET NAM VIET NAM
![Page 28: 02 nguyen t hong van ta](https://reader031.fdocuments.us/reader031/viewer/2022020307/55a4f87d1a28ab9a6e8b462f/html5/thumbnails/28.jpg)
THANK YOU!
12/03/14Covidien | | Confidential28 |
NGUYỄN THỊ HỒNG VÂNVIET NAM
Email: [email protected]